Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

87 ta ish

Ish: Naringenin as a potent anti-amyloidogenic polyphenol against a-synuclein aggregation: a computational approach

  1. Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations

    Benjamin Dehay, Mathieu Bourdenx, Philippe Gorry +9

    Sharh maqola20152 iqtibos
    ABI

  2. 7,8‐dihydroxyflavone Ameliorates Motor Deficits Via Suppressing <i>α</i> ‐synuclein Expression and Oxidative Stress in the <scp>MPTP</scp> ‐induced Mouse Model of Parkinson's Disease

    Xiaohuan Li, Chunfang Dai, Long Chen +3

    Maqola20162 iqtibos
    ABI

  3. Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice

    Darrell Sawmiller, Ahsan Habib, Song Li +8

    Maqola20162 iqtibos
    ABI

  4. Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models

    Hayate Javed, Mohamed Fizur Nagoor Meeran, Sheikh Azimullah +3

    Sharh maqola20192 iqtibos
    ABI

  5. Protective Effects of Flavonoids against Alzheimer’s Disease: Pathological Hypothesis, Potential Targets, and Structure–Activity Relationship

    Jiao Li, Min Sun, Xiaodong Cui +1

    Sharh maqola20222 iqtibos
    ABI

  6. Evaluation of Expression of Cytochrome P450 Aromatase and Inflammatory, Oxidative, and Apoptotic Markers in Testicular Tissue of Obese Rats (Pre)Treated with Garlic Powder

    Li Baicheng, Jia Li, Abolfazl Akbari +2

    Maqola20232 iqtibos
    ABI

  7. Computational insight into in silico analysis and molecular dynamics simulation of the dimer interface residues of ALS-linked hSOD1 forms in apo/holo states: a combined experimental and bioinformatic perspective

    Hamza Dakhil Zaji, Bagher Seyedalipour, Haider Munzer Hanun +3

    Maqola20232 iqtibos
    ABI

  8. The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma

    Nasim Ebrahimi, Nazanin Pazhouhesh Far, Siavash Seifollahy Fakhr +11

    Sharh maqola20232 iqtibos
    ABI

  9. Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami

    Yasamin Sharbatdar, Ronak Mousavian, Seyed Mostafa Noorbakhsh Varnosfaderani +9

    Sharh maqola20232 iqtibos
    ABI

  10. Polyphenolic flavonoid compounds act as the inhibitory potential of aggregation process: Implications for the prevention and therapeutics against FALS-associated D101G SOD1 mutant

    Hussein maitham Qassim, Bagher Seyedalipour, Payam Baziyar +1

    Maqola20232 iqtibos
    ABI

  11. Fighting against amyotrophic lateral sclerosis (ALS) with flavonoids: a computational approach to inhibit superoxide dismutase (SOD1) mutant aggregation

    Seyed Mostafa Noorbakhsh Varnosfaderani, Melika Sadat Haeri, Ali Sam Arian +7

    Maqola20232 iqtibos
    ABI

  12. Mutation/metal deficiency in the "electrostatic loop" enhanced aggregation process in apo/holo SOD1 variants: implications for ALS diseases

    Faezeh Ashkaran, Bagher Seyedalipour, Payam Baziyar +1

    Maqola20242 iqtibos
    ABI

  13. Discovering the therapeutic potential of Naringenin in diabetes related to GLUT-4 and its regulatory factors: A computational approach

    Ali Khakpour, Shamim Ghiabi, Ali Kazemi Babaheydari +4

    Maqola20242 iqtibos
    ABI

  14. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  15. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  16. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  17. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI